Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Horizon Therapeutics Public Limited stock logo
HZNP
Horizon Therapeutics Public
$116.30
$115.72
$60.03
$116.38
$26.63B1.032.50 million shsN/A
Medidata Solutions Inc stock logo
MDSO
Medidata Solutions
$92.22
$92.20
$60.10
$98.60
$5.76B1.221.24 million shs7.30 million shs
Sartorius Aktiengesellschaft stock logo
SARTF
Sartorius Aktiengesellschaft
$252.54
+1.8%
$282.78
$198.00
$338.07
N/A0.973 shs3 shs
Startek, Inc. stock logo
SRT
Startek
$4.42
$4.38
$2.64
$4.53
$178.35M1.32107,733 shsN/A
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
$12.78
-1.6%
$14.40
$12.53
$30.41
$2.17B0.975.36 million shs6.21 million shs
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Horizon Therapeutics Public Limited stock logo
HZNP
Horizon Therapeutics Public
0.00%0.00%0.00%0.00%+4.96%
Medidata Solutions Inc stock logo
MDSO
Medidata Solutions
0.00%0.00%0.00%0.00%0.00%
Sartorius Aktiengesellschaft stock logo
SARTF
Sartorius Aktiengesellschaft
+1.83%+1.83%-12.92%-12.75%-17.17%
Startek, Inc. stock logo
SRT
Startek
0.00%0.00%0.00%0.00%+41.67%
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-1.65%-1.77%-11.25%-35.42%-50.31%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Horizon Therapeutics Public Limited stock logo
HZNP
Horizon Therapeutics Public
N/AN/AN/AN/AN/AN/AN/AN/A
Medidata Solutions Inc stock logo
MDSO
Medidata Solutions
N/AN/AN/AN/AN/AN/AN/AN/A
Sartorius Aktiengesellschaft stock logo
SARTF
Sartorius Aktiengesellschaft
N/AN/AN/AN/AN/AN/AN/AN/A
Startek, Inc. stock logo
SRT
Startek
N/AN/AN/AN/AN/AN/AN/AN/A
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
3.0453 of 5 stars
4.21.00.00.02.32.51.3

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Horizon Therapeutics Public Limited stock logo
HZNP
Horizon Therapeutics Public
2.00
HoldN/AN/A
Medidata Solutions Inc stock logo
MDSO
Medidata Solutions
N/AN/AN/AN/A
Sartorius Aktiengesellschaft stock logo
SARTF
Sartorius Aktiengesellschaft
2.00
HoldN/AN/A
Startek, Inc. stock logo
SRT
Startek
2.00
Hold$4.757.47% Upside
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
2.35
Hold$18.7346.58% Upside

Current Analyst Ratings

Latest TDOC, HZNP, SRT, SARTF, and MDSO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/29/2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$17.00 ➝ $15.00
4/26/2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$26.00 ➝ $21.00
4/26/2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$25.00 ➝ $18.00
4/26/2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetIn-Line ➝ In-Line$15.00 ➝ $14.00
4/26/2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$16.00 ➝ $15.00
4/26/2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$21.00 ➝ $16.00
4/26/2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$25.00 ➝ $20.00
4/26/2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$28.00 ➝ $25.00
4/26/2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
4/5/2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
(Data available from 5/4/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Horizon Therapeutics Public Limited stock logo
HZNP
Horizon Therapeutics Public
$3.63B7.34$7.05 per share16.49$22.38 per share5.20
Medidata Solutions Inc stock logo
MDSO
Medidata Solutions
$635.70M9.06$1.69 per share54.55$10.32 per share8.94
Sartorius Aktiengesellschaft stock logo
SARTF
Sartorius Aktiengesellschaft
$3.67BN/A$29.54 per share8.55$81.84 per shareN/A
Startek, Inc. stock logo
SRT
Startek
$385.07M0.46$1.48 per share2.98$6.25 per share0.71
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
$2.60B0.83$0.80 per share16.01$13.50 per share0.95

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Horizon Therapeutics Public Limited stock logo
HZNP
Horizon Therapeutics Public
$521.48M$1.8762.1920.553.9612.02%20.46%11.52%N/A
Medidata Solutions Inc stock logo
MDSO
Medidata Solutions
$51.92M$0.9696.0691.316.956.43%8.64%5.73%N/A
Sartorius Aktiengesellschaft stock logo
SARTF
Sartorius Aktiengesellschaft
$221.98M$2.36107.0133.81N/A4.50%10.57%3.24%N/A
Startek, Inc. stock logo
SRT
Startek
-$2.26M-$0.53N/A9.020.60-5.81%12.22%5.36%N/A
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-$220.37M-$1.41N/AN/AN/A-8.90%-10.13%-5.37%7/23/2024 (Estimated)

Latest TDOC, HZNP, SRT, SARTF, and MDSO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/25/2024Q1 2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-$0.47-$0.49-$0.02-$0.49$637.31 million$646.13 million    
2/20/2024Q4 2023
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-$0.22-$0.17+$0.05-$0.17$670.79 million$660.50 million      
2/16/2024Q4 2023
Sartorius Aktiengesellschaft stock logo
SARTF
Sartorius Aktiengesellschaft
$1.31$1.01-$0.30$1.89$900.00 million$915.06 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Horizon Therapeutics Public Limited stock logo
HZNP
Horizon Therapeutics Public
N/AN/AN/AN/AN/A
Medidata Solutions Inc stock logo
MDSO
Medidata Solutions
N/AN/AN/AN/AN/A
Sartorius Aktiengesellschaft stock logo
SARTF
Sartorius Aktiengesellschaft
N/AN/AN/AN/AN/A
Startek, Inc. stock logo
SRT
Startek
N/AN/AN/AN/AN/A
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Horizon Therapeutics Public Limited stock logo
HZNP
Horizon Therapeutics Public
0.48
4.27
4.09
Medidata Solutions Inc stock logo
MDSO
Medidata Solutions
0.27
2.56
2.56
Sartorius Aktiengesellschaft stock logo
SARTF
Sartorius Aktiengesellschaft
1.82
1.47
0.69
Startek, Inc. stock logo
SRT
Startek
0.32
1.24
1.24
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
0.67
3.82
3.47

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Horizon Therapeutics Public Limited stock logo
HZNP
Horizon Therapeutics Public
2,115228.99 million223.96 millionOptionable
Medidata Solutions Inc stock logo
MDSO
Medidata Solutions
1,99862.46 millionN/AOptionable
Sartorius Aktiengesellschaft stock logo
SARTF
Sartorius Aktiengesellschaft
14,614N/AN/ANot Optionable
Startek, Inc. stock logo
SRT
Startek
33,00040.35 million38.69 millionOptionable
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
5,600169.59 million167.98 millionOptionable

TDOC, HZNP, SRT, SARTF, and MDSO Headlines

SourceHeadline
Laizer Kornwasser Sells 10,411 Shares of Teladoc Health, Inc. (NYSE:TDOC) StockLaizer Kornwasser Sells 10,411 Shares of Teladoc Health, Inc. (NYSE:TDOC) Stock
americanbankingnews.com - May 4 at 7:36 AM
Michael Willem Waters Sells 5,793 Shares of Teladoc Health, Inc. (NYSE:TDOC) StockMichael Willem Waters Sells 5,793 Shares of Teladoc Health, Inc. (NYSE:TDOC) Stock
americanbankingnews.com - May 4 at 7:00 AM
Insider Sale at Teladoc Health Inc (TDOC): President of Enterprise Growth Sells SharesInsider Sale at Teladoc Health Inc (TDOC): President of Enterprise Growth Sells Shares
finance.yahoo.com - May 4 at 12:00 AM
Teladoc Health, Inc. (NYSE:TDOC) COO Sells $73,513.17 in StockTeladoc Health, Inc. (NYSE:TDOC) COO Sells $73,513.17 in Stock
insidertrades.com - May 3 at 7:31 AM
TDOC ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Teladoc Health, Inc. Shareholders Who Lost MoneyTDOC ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Teladoc Health, Inc. Shareholders Who Lost Money
accesswire.com - May 3 at 7:20 AM
Teladoc Health, Inc. (NYSE:TDOC) COO Michael Willem Waters Sells 5,793 SharesTeladoc Health, Inc. (NYSE:TDOC) COO Michael Willem Waters Sells 5,793 Shares
marketbeat.com - May 2 at 7:32 PM
Teladoc: Even UnitedHealth Is Turning Its Back On TelehealthTeladoc: Even UnitedHealth Is Turning Its Back On Telehealth
seekingalpha.com - May 2 at 4:00 PM
Levi & Korsinsky Reminds Teladoc Investors of the Ongoing Investigation into Potential Violations of Securities Laws - TDOCLevi & Korsinsky Reminds Teladoc Investors of the Ongoing Investigation into Potential Violations of Securities Laws - TDOC
accesswire.com - May 2 at 7:20 AM
Stock Market Crash Warning: Dont Get Caught Holding These 3 Cathie Wood StocksStock Market Crash Warning: Don't Get Caught Holding These 3 Cathie Wood Stocks
investorplace.com - May 2 at 6:00 AM
Teladoc Health, Inc. Forecasted to Post FY2024 Earnings of ($1.00) Per Share (NYSE:TDOC)Teladoc Health, Inc. Forecasted to Post FY2024 Earnings of ($1.00) Per Share (NYSE:TDOC)
americanbankingnews.com - May 2 at 2:04 AM
Teladoc Health Is Providing Free Virtual Health Care Services to Oklahoma Residents Impacted by TornadoesTeladoc Health Is Providing Free Virtual Health Care Services to Oklahoma Residents Impacted by Tornadoes
finance.yahoo.com - May 1 at 7:21 PM
Teladoc Health, Inc. (NYSE:TDOC) Expected to Post FY2024 Earnings of ($1.00) Per ShareTeladoc Health, Inc. (NYSE:TDOC) Expected to Post FY2024 Earnings of ($1.00) Per Share
marketbeat.com - May 1 at 8:36 AM
An Investigation Has Commenced on Behalf of Teladoc Health, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your TDOC Losses.An Investigation Has Commenced on Behalf of Teladoc Health, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your TDOC Losses.
accesswire.com - May 1 at 7:25 AM
Teladoc Health (TDOC) Q1 Loss Widens on Decline in VisitsTeladoc Health (TDOC) Q1 Loss Widens on Decline in Visits
zacks.com - April 30 at 1:41 PM
Teladoc Health, Inc. (NYSE:TDOC) Q1 2024 Earnings Call TranscriptTeladoc Health, Inc. (NYSE:TDOC) Q1 2024 Earnings Call Transcript
finance.yahoo.com - April 30 at 1:17 PM
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Teladoc (TDOC), R1 RCM (RCM) and Gilead Sciences (GILD)Analysts’ Opinions Are Mixed on These Healthcare Stocks: Teladoc (TDOC), R1 RCM (RCM) and Gilead Sciences (GILD)
markets.businessinsider.com - April 30 at 8:16 AM
Teladoc Health (NYSE:TDOC) Price Target Cut to $15.00 by Analysts at Wells Fargo & CompanyTeladoc Health (NYSE:TDOC) Price Target Cut to $15.00 by Analysts at Wells Fargo & Company
americanbankingnews.com - April 30 at 6:20 AM
Wells Fargo & Company Cuts Teladoc Health (NYSE:TDOC) Price Target to $15.00Wells Fargo & Company Cuts Teladoc Health (NYSE:TDOC) Price Target to $15.00
marketbeat.com - April 29 at 3:09 PM
Evercore ISI Lowers Teladoc Health (NYSE:TDOC) Price Target to $14.00Evercore ISI Lowers Teladoc Health (NYSE:TDOC) Price Target to $14.00
americanbankingnews.com - April 28 at 6:32 AM
Needham & Company LLC Reiterates "Hold" Rating for Teladoc Health (NYSE:TDOC)Needham & Company LLC Reiterates "Hold" Rating for Teladoc Health (NYSE:TDOC)
americanbankingnews.com - April 28 at 6:32 AM
Stifel Nicolaus Lowers Teladoc Health (NYSE:TDOC) Price Target to $16.00Stifel Nicolaus Lowers Teladoc Health (NYSE:TDOC) Price Target to $16.00
americanbankingnews.com - April 28 at 6:32 AM
TD Cowen Lowers Teladoc Health (NYSE:TDOC) Price Target to $15.00TD Cowen Lowers Teladoc Health (NYSE:TDOC) Price Target to $15.00
americanbankingnews.com - April 28 at 6:32 AM
Barclays Lowers Teladoc Health (NYSE:TDOC) Price Target to $20.00Barclays Lowers Teladoc Health (NYSE:TDOC) Price Target to $20.00
americanbankingnews.com - April 28 at 6:32 AM
Teladoc Health (NYSE:TDOC) Price Target Cut to $25.00Teladoc Health (NYSE:TDOC) Price Target Cut to $25.00
americanbankingnews.com - April 28 at 6:32 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Horizon Therapeutics Public logo

Horizon Therapeutics Public

NASDAQ:HZNP
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. Its portfolio comprises 12 medicines in the areas of rare diseases, gout, ophthalmology, and inflammation. It markets TEPEZZA (teprotumumab-trbw) for intravenous infusion; KRYSTEXXA (pegloticase injection) for intravenous infusion; RAVICTI (glycerol phenylbutyrate) oral liquid; PROCYSBI (cysteamine bitartrate) delayed-release capsules and granules for oral use; ACTIMMUNE (interferon gamma-1b) injection for subcutaneous use; BUPHENYL (sodium phenylbutyrate) tablets and powder for oral use; QUINSAIR (levofloxacin) solution for inhalation; and UPLIZNA (inebilizumab-cdon) injection for intravenous use. The company also markets PENNSAID (diclofenac sodium topical solution) for topical use; DUEXIS (ibuprofen/famotidine) tablets for oral use; RAYOS (prednisone) delayed-release tablets for oral use; and VIMOVO (naproxen/esomeprazole magnesium) delayed-release tablets for oral use. It has collaboration agreements with HemoShear Therapeutics, LLC; Alpine Immune Sciences, Inc.; Halozyme Therapeutics, Inc.; Arrowhead Pharmaceuticals, Inc.; Q32 Bio Inc.; and Xeris Biopharma Holdings, Inc. The company was formerly known as Horizon Pharma Public Limited Company and changed its name to Horizon Therapeutics Public Limited Company in May 2019. Horizon Therapeutics Public Limited Company was founded in 2005 and is headquartered in Dublin, Ireland.
Medidata Solutions logo

Medidata Solutions

NASDAQ:MDSO
Medidata Solutions, Inc. provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development and commercialization of new therapies. The company's platform solutions include data capture and management, and trial planning and management. It also provides professional services, such as implementation, sponsor enablement, strategic consulting, partner support, and e-learning and training. The company markets and sells its cloud-based solutions through a direct sales force and through relationships with channel and strategic partners. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; academic research centers, government, and other non-profit organizations; and other non-profit organizations; and contract research organizations and other entities engaged in clinical trials. The company was founded in 1999 and is headquartered in New York, New York.
Sartorius Aktiengesellschaft logo

Sartorius Aktiengesellschaft

OTCMKTS:SARTF
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers. It also provides live-cell analysis systems, reagents and consumables, support and services, and live-cell imaging and analysis software; contract manufacturing and integration, membranes and devices, weigh cells, and data analytics, as well as connectivity, and pipetting and dispensing modules; electronic and mechanical pipettes, pipette tips, bottle-top dispensers, and pipette controllers and accessories; process automation platform and software, sensors and analyzers, biomolecule analysis tools, and data analytics software; chromatography consumables, columns, and systems; and biolayer interferometry products. In addition, the company offers water purification systems; surface plasmon resonance; lab balances, pipette calibration, mass comparators and metrology, moisture analyzers, equipment manufacturer cells, weights and weight sets, paint mixing solutions, and weighing accessories; and process filtration. Further, the company provides bioprocess consulting and engineering, biologics testing, media and process, instrument, octet service and support, and validation services. It serves the life science research, biopharmaceutical manufacturing, pharmaceutical quality control, cell and gene therapy, and applied industries. Sartorius Aktiengesellschaft was founded in 1870 and is headquartered in Göttingen, Germany.
Startek logo

Startek

NYSE:SRT
StarTek, Inc., a business process outsourcing company, provides customer experience, digital transformation, and technology services in various markets. The company primarily offers customer engagement, omnichannel engagement, social media, customer intelligence analytics, work from home, and back-office services under the Startek and Aegis brands. It also offers Startek cloud, a hybrid omni-cloud platform integrated with artificial intelligence capabilities, which enables agents to work in remote and home-based roles for increased business agility and continuity. The company serves telecom, e-commerce and consumer, financial and business services, cable and media, travel and hospitality, technology, education and healthcare, energy, and other industries in the Americas, India, Sri Lanka, Malaysia, South Africa, Australia, and internationally. StarTek, Inc. was founded in 1987 and is headquartered in Denver, Colorado.
Teladoc Health logo

Teladoc Health

NYSE:TDOC
Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.